Login / Signup

Tolerability of treatment with pirfenidone or nintedanib for pulmonary fibrosis in the real world.

Takashi OguraHideya Kitamura
Published in: Respirology (Carlton, Vic.) (2017)
Keyphrases
  • pulmonary fibrosis
  • idiopathic pulmonary fibrosis
  • open label
  • interstitial lung disease
  • combination therapy
  • clinical trial
  • systemic sclerosis
  • double blind